Pharmacists in Columbia, Missouri


237 Pharmacists found in Columbia
male pharmacist

Thomas James Mcsherry, RPH


Pharmacist
1 Hospital Dr, Columbia, MO 65203
573-268-7620    

male pharmacist

Thomas Michael Sandifer


Pharmacist
800 Hospital Dr, Columbia, MO 65201
573-814-6000    

male pharmacist

Thuong Duy Vo, RPH


Pharmacist
800 Hospital Dr, Columbia, MO 65201
573-814-6000    



male pharmacist

Dr. Todd Robert Blanton, PHARMD


Pharmacist
415 Conley Rd, Columbia, MO 65201
573-499-1933    

male pharmacist

Dr. Tom William Greenlee, PHARMD


Pharmacist
25 Conley Rd, Columbia, MO 65201
573-442-7706     573-442-8028

female pharmacist

Mrs. Toni Lynne Doster


Pharmacist
3100 W Broadway, Columbia, MO 65203
573-447-2144     573-445-8227

female pharmacist

Dr. Tonya Campbell, PHARMD



800 Hospital Dr, Columbia, MO 65201
573-814-6000    

male pharmacist

Trevor T Isringhausen


Pharmacist
1506 E Broadway Ste 118, Columbia, MO 65201
573-449-5366     573-443-7938

male pharmacist

Triston Dale Brownfield, R.PH.


Pharmacist
1 S Keene St, Columbia, MO 65201
573-876-8410    

female pharmacist

Vanessa Lynn Gonzalez, PHARMD


Pharmacist
800 Hospital Dr, Columbia, MO 65201
573-814-6000    

female pharmacist

Dr. Veronica Parks, PHARMD


Pharmacist
1 Hospital Dr Rm 1l29, Columbia, MO 65212
573-882-8625    

male pharmacist

Dr. William Arnold Morrissey, PHARMD


Pharmacist
700 N Providence Rd, Columbia, MO 65203
573-442-0194    

male pharmacist

William Kennent Dickinson, R.PH.


Pharmacist
800 Hospital Dr, Pharmacy Service (119), Columbia, MO 65201
573-814-6000     573-814-6536


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.